Respiratory infection rates differ between geographically distant paediatric cystic fibrosis cohorts

Kathryn A Ramsey1, Emily Hart2, Lidija Turkovic3

  • 1Telethon Kids Institute, University of Western Australia, Perth, Australia; Cystic Fibrosis Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; These authors contributed equally to this paper.

ERJ Open Research
|December 14, 2016
PubMed

Insights

Children with cystic fibrosis (CF) in Melbourne acquired respiratory infections earlier and had worse lung disease compared to Perth. Geographical factors may influence early infection and CF outcomes.

Area of Science:

  • Pediatrics
  • Pulmonology
  • Infectious Diseases

Background:

  • Respiratory infections significantly impact lung health in children with cystic fibrosis (CF).
  • Geographical variations in infection prevalence can affect CF patient outcomes.

Purpose of the Study:

  • To compare the prevalence of respiratory infections and lung disease in early life between two geographically distinct cystic fibrosis (CF) treatment centers in Australia.
  • To identify potential factors contributing to observed differences in infection and disease severity.

Main Methods:

  • A surveillance program evaluated lower airway microbiology, inflammation, and structural lung disease in 260 children (0-8 years) with CF over 1032 visits.
  • Data were collected from CF treatment centers in Melbourne and Perth, Australia.

Main Results:

  • Melbourne patients showed higher rates of respiratory pathogen culture positivity across all age groups (OR 1.85).
  • Infants (<2 years) in Melbourne had increased neutrophil elastase (OR 3.11).
  • Bronchiectasis (OR 2.02) and air trapping (OR 2.53) were more common in Melbourne children aged 2-5 years, with worse structural lung disease in older children (>5 years). Hospitalization and antibiotic rates were similar between centers.

Conclusions:

  • Geographical differences in early respiratory infection acquisition may contribute to variability in cystic fibrosis outcomes between treatment centers.
  • No procedural differences were identified to explain the observed disparities in pathogen prevalence.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
982
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
597
Physical Assessment of the Respiratory Tract II: Inspection01:27

Physical Assessment of the Respiratory Tract II: Inspection

Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration...
1.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.7K
Assessment of Ventilation I: Respiratory Rate01:20

Assessment of Ventilation I: Respiratory Rate

Assessment of Ventilation
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
2.5K